Atıf Formatları
VEGF, HIF-1 alpha and CD34 expressions in gastric tumors (tms): Relationship with pathological factors and prognostic impact on survival.
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

D. Cabuk Et Al. , "VEGF, HIF-1 alpha and CD34 expressions in gastric tumors (tms): Relationship with pathological factors and prognostic impact on survival.," 41st Annual Meeting of the American-Society-of-Clinical-Oncology , vol.23, Florida, United States Of America, 2005

Cabuk, D. Et Al. 2005. VEGF, HIF-1 alpha and CD34 expressions in gastric tumors (tms): Relationship with pathological factors and prognostic impact on survival.. 41st Annual Meeting of the American-Society-of-Clinical-Oncology , (Florida, United States Of America).

Cabuk, D., BAŞARAN, G., Yumuk, P., Celikel, C., Dane, F., Iyikesici, M., ... EKENEL, M.(2005). VEGF, HIF-1 alpha and CD34 expressions in gastric tumors (tms): Relationship with pathological factors and prognostic impact on survival. . 41st Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, United States Of America

Cabuk, D Et Al. "VEGF, HIF-1 alpha and CD34 expressions in gastric tumors (tms): Relationship with pathological factors and prognostic impact on survival.," 41st Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, United States Of America, 2005

Cabuk, D Et Al. "VEGF, HIF-1 alpha and CD34 expressions in gastric tumors (tms): Relationship with pathological factors and prognostic impact on survival.." 41st Annual Meeting of the American-Society-of-Clinical-Oncology , Florida, United States Of America, 2005

Cabuk, D. Et Al. (2005) . "VEGF, HIF-1 alpha and CD34 expressions in gastric tumors (tms): Relationship with pathological factors and prognostic impact on survival.." 41st Annual Meeting of the American-Society-of-Clinical-Oncology , Florida, United States Of America.

@conferencepaper{conferencepaper, author={D Cabuk Et Al. }, title={VEGF, HIF-1 alpha and CD34 expressions in gastric tumors (tms): Relationship with pathological factors and prognostic impact on survival.}, congress name={41st Annual Meeting of the American-Society-of-Clinical-Oncology}, city={Florida}, country={United States Of America}, year={2005}}